Search

everythinglearnresearchcommunity

for

Search:↓

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Hair loss condition FFA was seen before the appearance of skin depigmentation vitiligo in a patient.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

The document explains various skin conditions in cats and how to diagnose and treat them.

Follicle Stimulating Hormone is important for fertility.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

Alopecia areata does not affect areas with psoriasis plaques.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Leflunomide is more likely to help treat alopecia areata than cause it.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

Probe detects finasteride with high selectivity and low detection limit.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.